Due to the ubiquitous nature of the cytokine, TGF-β direct inhibition may not be the most promising target for the treatment of hydrocephalus, but it certainly represents an important group of signaling pathways to be explored for their involvement in the development of hydrocephalus. The gene discussed is TGFB1; the disease is Hydrocephalus.